The 6 W’s: Who, what, where, when, why and what of it …
GRNOPC1, an oligodendrocyte progenitor derived from human embryonic stem cells, for myelin repair in a non-human primate model supports further investigation Read more…
Good morning! Here’s what you … might need to know to start the day… Read more…
End of Day, Cause and Effect … Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
AMEX: CUR receives FDA approval to dose patients in Cervical Region in ongoing ALS Trial Read more…
Receives Singapore Health Sciences Authority (HSA) regulatory clearance to begin P2 trial Read more…
Good morning! Here’s what you … might need to know to start the day… Read more…
End of Day, Cause and Effect … Read more…
Dr Andrew Pecora MD FACP CPE, NeoStem’s Chief Medical Officer has forwarded 3 papers Read more…
Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.